These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

194 related items for PubMed ID: 1564523

  • 1. A homologue of dystrophin is expressed at the blood vessel membrane of DMD and BMD patients: immunological evidence.
    Augier N, Boucraut J, Léger J, Anoal M, Nicholson LV, Voelkel MA, Léger JJ, Pellissier JF.
    J Neurol Sci; 1992 Feb; 107(2):233-8. PubMed ID: 1564523
    [Abstract] [Full Text] [Related]

  • 2. Dystrophin or a "related protein" in Duchenne muscular dystrophy?
    Nicholson LV, Johnson MA, Davison K, O'Donnell E, Falkous G, Barron M, Harris JB.
    Acta Neurol Scand; 1992 Jul; 86(1):8-14. PubMed ID: 1519480
    [Abstract] [Full Text] [Related]

  • 3. Dystrophin as a diagnostic marker in Duchenne and Becker muscular dystrophy. Correlation of immunofluorescence and western blot.
    Voit T, Stuettgen P, Cremer M, Goebel HH.
    Neuropediatrics; 1991 Aug; 22(3):152-62. PubMed ID: 1944822
    [Abstract] [Full Text] [Related]

  • 4. Is the maintainance of the C-terminus domain of dystrophin enough to ensure a milder Becker muscular dystrophy phenotype?
    Vainzof M, Takata RI, Passos-Bueno MR, Pavanello RC, Zatz M.
    Hum Mol Genet; 1993 Jan; 2(1):39-42. PubMed ID: 8490621
    [Abstract] [Full Text] [Related]

  • 5. Xp21 dystrophin and 6q dystrophin-related protein. Comparative immunolocalization using multiple antibodies.
    Voit T, Haas K, Léger JO, Pons F, Léger JJ.
    Am J Pathol; 1991 Nov; 139(5):969-76. PubMed ID: 1951635
    [Abstract] [Full Text] [Related]

  • 6. Dystrophin in skeletal muscle. II. Immunoreactivity in patients with Xp21 muscular dystrophy.
    Nicholson LV, Davison K, Johnson MA, Slater CR, Young C, Bhattacharya S, Gardner-Medwin D, Harris JB.
    J Neurol Sci; 1989 Dec; 94(1-3):137-46. PubMed ID: 2693618
    [Abstract] [Full Text] [Related]

  • 7. Is dystrophin labelling always discontinuous in Becker muscular dystrophy?
    Slater CR, Nicholson LV.
    J Neurol Sci; 1991 Feb; 101(2):187-92. PubMed ID: 2033404
    [Abstract] [Full Text] [Related]

  • 8. Immunofluorescence dystrophin study in Duchenne dystrophy through the concomitant use of two antibodies directed against the carboxy-terminal and the amino-terminal region of the protein.
    Vainzof M, Zubrzycka-Gaarn EE, Rapaport D, Passos-Bueno MR, Pavanello RC, Pavanello-Filho I, Zatz M.
    J Neurol Sci; 1991 Feb; 101(2):141-7. PubMed ID: 1709683
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Preservation of the C-terminus of dystrophin molecule in the skeletal muscle from Becker muscular dystrophy.
    Arahata K, Beggs AH, Honda H, Ito S, Ishiura S, Tsukahara T, Ishiguro T, Eguchi C, Orimo S, Arikawa E.
    J Neurol Sci; 1991 Feb; 101(2):148-56. PubMed ID: 2033400
    [Abstract] [Full Text] [Related]

  • 11. Dystrophin analysis using a panel of anti-dystrophin antibodies in Duchenne and Becker muscular dystrophy.
    Muntoni F, Mateddu A, Cianchetti C, Marrosu MG, Clerk A, Cau M, Congiu R, Cao A, Melis MA.
    J Neurol Neurosurg Psychiatry; 1993 Jan; 56(1):26-31. PubMed ID: 8429320
    [Abstract] [Full Text] [Related]

  • 12. A homologue of dystrophin is expressed at the neuromuscular junctions of normal individuals and DMD patients, and of normal and mdx mice. Immunological evidence.
    Pons F, Augier N, Léger JO, Robert A, Tomé FM, Fardeau M, Voit T, Nicholson LV, Mornet D, Léger JJ.
    FEBS Lett; 1991 Apr 22; 282(1):161-5. PubMed ID: 1709117
    [Abstract] [Full Text] [Related]

  • 13. Integrated study of 100 patients with Xp21 linked muscular dystrophy using clinical, genetic, immunochemical, and histopathological data. Part 1. Trends across the clinical groups.
    Nicholson LV, Johnson MA, Bushby KM, Gardner-Medwin D, Curtis A, Ginjaar IB, den Dunnen JT, Welch JL, Butler TJ, Bakker E.
    J Med Genet; 1993 Sep 22; 30(9):728-36. PubMed ID: 8411067
    [Abstract] [Full Text] [Related]

  • 14. Dystrophin immunocytochemistry in muscle culture: detection of a carrier of Duchenne muscular dystrophy.
    Miranda AF, Francke U, Bonilla E, Martucci G, Schmidt B, Salviati G, Rubin M.
    Am J Med Genet; 1989 Feb 22; 32(2):268-73. PubMed ID: 2648829
    [Abstract] [Full Text] [Related]

  • 15. Differentiation of Duchenne and Becker muscular dystrophy phenotypes with amino- and carboxy-terminal antisera specific for dystrophin.
    Bulman DE, Murphy EG, Zubrzycka-Gaarn EE, Worton RG, Ray PN.
    Am J Hum Genet; 1991 Feb 22; 48(2):295-304. PubMed ID: 1990838
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Dystrophin analysis in the diagnosis of childhood muscular dystrophy: an immunohistochemical study of 75 cases.
    Jay V, Becker LE, Ackerley C, Ray P.
    Pediatr Pathol; 1993 Feb 22; 13(5):635-57. PubMed ID: 8247961
    [Abstract] [Full Text] [Related]

  • 18. [Membrane changes in Duchenne/Becker muscular dystrophy: lectin binding and localization of dystrophin].
    Voit T, Patel K, Sewry CA, Strong PN, Dubowitz V, Dunn MJ.
    Monatsschr Kinderheilkd; 1989 Jan 22; 137(1):20-7. PubMed ID: 2646527
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Variability in clinical, genetic and protein abnormalities in manifesting carriers of Duchenne and Becker muscular dystrophy.
    Bushby KM, Goodship JA, Nicholson LV, Johnson MA, Haggerty ID, Gardner-Medwin D.
    Neuromuscul Disord; 1993 Jan 22; 3(1):57-64. PubMed ID: 8329890
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.